Entrepreneur and Director Tayyofficial Is Having a Phenomenal Year 
The Path to Start-Up Success: Natali Budzei, Dubai-Based Ukrainian Entrepreneur, Launches New Luxury Yoga Mat, Explains Why UAE Is Where Every Dream Turns Into Reality 
XPhyto Provides Updated Comments on Promotional and Marketing Activity Entrepreneur and Director Tayyofficial Is Having a Phenomenal Year
PHILADELPHIA, PA / ACCESSWIRE / February 27, 2021 / Hailing from Philadelphia, Tayyofficial is making waves…
The Path to Start-Up Success: Natali Budzei, Dubai-Based Ukrainian Entrepreneur, Launches New Luxury Yoga Mat, Explains Why UAE Is Where Every Dream Turns Into Reality
ABUJA, NIGERIA / ACCESSWIRE / February 26, 2021 / The United Arab Emirates is fast…
XPhyto Provides Updated Comments on Promotional and Marketing Activity
VANCOUVER, BC / ACCESSWIRE / February 26, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) (“XPhyto” or…
Annual financial report 2020
FINANCIERE DE TUBIZE SA/NV Allée de la Recherche 60, 1070 Brussels Contact: Anne Sophie Pijcke,…
Imara to Webcast Conference Call of Full Year 2020 Financial Results and Business Highlights
BOSTON, Feb. 26, 2021 (GLOBE NEWSWIRE) — Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company…
NextCure to Host Virtual R&D Update Event on March 4, 2021
BELTSVILLE, Md., Feb. 26, 2021 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical…
Zomedica Corp. Announces Year End 2020 Financial Results
ANN ARBOR, Mich., Feb. 26, 2021 (GLOBE NEWSWIRE) — Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or…
The Get Real Movement Expands Programs to Promote Inclusivity and Acceptance in More Western Canadian Schools
With support from Shaw Communications, Get REAL will bring Inclusivity and Anti-Racism workshops to more…
Objectivity’s New CRAD/IRAD Program: Free for Government Partners
San Jose, Feb. 26, 2021 (GLOBE NEWSWIRE) — Objectivity, Inc., a US company and leader…
Ehave Inc. Reaches Milestone; Ketamine IV Therapy Provider KetaDASH to Launch Beta in Second Quarter 2021
KetaDASH plans to launch beta trial of its ketamine IV therapy using advanced vein technology….